Login to Your Account



Corgentech Series C Raises $50M For Bypass Research

By Randall Osborne


Wednesday, July 17, 2002
With a product in one Phase III trial and about to start another in peripheral bypass graft surgery, Corgentech Inc. took an infusion of $50 million in Series C financing that gives it enough cash to last "through the first or second quarter of 2004," said Richard Powers, vice president and chief financial officer. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription